Trial · NCT02075463
Adverse events35
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 35
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | URINARY TRACT INFECTION | Infections and infestations | GSK1278863 12 mg QD | 2 | 15 | |
| other | GASTROENTERITIS VIRAL | Infections and infestations | GSK1278863 12 mg QD | 1 | 15 | |
| other | INFLUENZA | Infections and infestations | GSK1278863 12 mg QD | 1 | 15 | |
| other | PNEUMONIA | Infections and infestations | GSK1278863 12 mg QD | 1 | 15 | |
| other | UPPER RESPIRATORY TRACT INFECTION | Infections and infestations | GSK1278863 12 mg QD | 1 | 15 | |
| other | NAUSEA | Gastrointestinal disorders | GSK1278863 12 mg QD | 3 | 15 | |
| other | VOMITING | Gastrointestinal disorders | GSK1278863 12 mg QD | 1 | 15 | |
| other | BLOOD CALCIUM DECREASED | Investigations | GSK1278863 12 mg QD | 1 | 15 | |
| other | BLOOD PRESSURE INCREASED | Investigations | GSK1278863 12 mg QD | 1 | 15 | |
| other | OCCULT BLOOD POSITIVE | Investigations | GSK1278863 12 mg QD | 1 | 15 | |
| other | FATIGUE | General disorders | GSK1278863 12 mg QD | 1 | 15 | |
| other | PYREXIA | General disorders | GSK1278863 12 mg QD | 1 | 15 | |
| other | ARTERIOVENOUS FISTULA SITE COMPLICATION | Injury, poisoning and procedural complications | GSK1278863 12 mg QD | 1 | 15 | |
| other | ARTERIOVENOUS FISTULA THROMBOSIS | Injury, poisoning and procedural complications | GSK1278863 12 mg QD | 1 | 15 | |
| other | HYPERKALAEMIA | Metabolism and nutrition disorders | GSK1278863 12 mg QD | 1 | 15 | |
| other | MALNUTRITION | Metabolism and nutrition disorders | GSK1278863 12 mg QD | 1 | 15 | |
| other | PLEURAL EFFUSION | Respiratory, thoracic and mediastinal disorders | GSK1278863 12 mg QD | 2 | 15 | |
| other | BRACHIOCEPHALIC VEIN STENOSIS | Vascular disorders | GSK1278863 12 mg QD | 1 | 15 | |
| other | VENOUS STENOSIS | Vascular disorders | GSK1278863 12 mg QD | 1 | 15 | |
| other | PAIN IN EXTREMITY | Musculoskeletal and connective tissue disorders | GSK1278863 12 mg QD | 1 | 15 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02075463/events